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Identification of Intermediate Cell Types by
Keratin Expression in the Developing
Human Prostate
Yong Xue,1 Frank Smedts,2 Frans M.J. Debruyne,1 Jean J.M.C.H. de la Rosette,1
and Jack A. Schalken1*
1Department of Urology, University Hospital Nijmegen, Nijmegen, The Netherlands
2Department of Pathology, Foundation of Collaborating Hospitals in East Groningen,
Winschoten, The Netherlands
BACKGROUND. The secretory acini of the adult human prostate contain basal, luminal, and
intermediate types of exocrine cells. Intermediate cells are thought to play an important role
in normal growth and neoplastic transformation. In this study we investigated whether this
cell type is present in early stages of prostate development, using keratin antibodies specific
for them.
METHODS. Autoptic tissue from 11 prepubertal and 5 normal adult prostates was immu-
nohistochemically stained with four keratin antibodies capable of specifically detecting basal,
luminal, or intermediate cell types.
RESULTS. Morphologically, in fetal prostate cells differentiation was often not evident. How-
ever, basally located cells usually displayed a basal-cell keratin-phenotype. Morphologically
similar cells with more luminal localization expressed keratins typical of luminal cells, or of
intermediate cells.
CONCLUSIONS. 1) In early stages of prostate development, cells with intermediate keratin-
phenotype can be identified. 2) Their large numbers comply with a hierarchical pathway of
cellular differentiation from basal to luminal cells. 3) The presence of intermediate cells at
such an early fetal age may reflect their regulatory function in prostate development. Prostate
34:292–301, 1998. © 1998 Wiley-Liss, Inc.
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INTRODUCTION
Although benign prostatic hyperplasia (BPH) is one
of the most common conditions in elderly men [1], our
knowledge concerning its etiology is fragmentary. The
correlation between adult neoplastic growth and fetal
prostate development was first hypothesized by Mc-
Neal [2]. He emphasized that BPH occurring later in
life is the result of a ‘‘reawakening’’ of the embryonic
capability in the adult, i.e., of the stromal inductive
potential on epithelial growth [2]. Prostatic early de-
velopment and morphogenesis are dependent on in-
ductive signals originating in the mesenchymal com-
partment [3]. Furthermore, adult urogenital epithelia
maintain the capability to respond to stromal media-
tors of growth and differentiation, and several peptide
growth factors have been implicated in the develop-
ment of BPH [4,5]. These studies on the embryology
and development of the prostate provide important
clues which may elucidate mechanisms of prostatic
neoplasia.
In characterizing epithelial cell differentiation, an-
tibodies against keratin (K) components of the cyto-
skeleton can be instrumental, as the 20 different mem-
bers of this family are expressed in specific combina-
tions in various types of epithelia. Moreover, their
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expression is related to specific stages of differentia-
tion (reviewed in Moll et al. [6], Ramaekers et al. [7],
and Nagle [8]). Previous keratin expression studies in
the fetal prostate showed that of 30–36-week of gesta-
tion, only basal-cell keratins are expressed. In the 7-
month neonate and 1-year-old infant, distinct changes
in keratin expression occur, and a population of cells
expressing basal-type keratins is found along with a
population expressing luminal-type keratins [9]. How-
ever, data concerning the exact keratin-phenotype of
these cells and possible transitions in keratin expres-
sion during fetal development are not available. At
present, the keratin-phenotype for prostate exocrine
epithelial cells comprises, among others, keratins 5
and 14, also called complex keratins found in basal
cells, while luminal cells contain, among others, ker-
atins 8 and 18, called simple keratins [10,11]. It is
thought that during differentiation, basal cells acquire
simple keratins (K8 + K18) and lose their basal-cell
keratins (K5 + K14).
Based on light and electron microscopic studies in
humans and dogs, a third cell type has been identified,
having characteristics of both basal and luminal cells
[12,13]. In the postnatal rat prostate these cells contain
both basal-cell keratins 5 and 15 and luminal-cell ker-
atins 8 and 18 [14]. Bonkhoff et al. [15] observed a
subset of basal cells which coexpress basal-cell kera-
tins and PSA (prostatic-specific antigen is usually only
expressed in luminal cells). This is considered evi-
dence for the presence of a group of cells with inter-
mediate differentiation [15]. Our own studies confirm
the presence of an intermediate cell type in the secre-
tory acini of the normal adult human prostate, in BPH,
in prostate carcinoma (PCa), and in involution-
regeneration processes in rat prostate [16–18]. We
demonstrated that these cells contain keratin 18 and
express the basal-keratin antibody RCK103. Based on
these observations we proposed that this cell type
could be the same as the amplifying cells described in
the stem-cell model [19].
Because knowledge concerning intermediate cells
in the developing human prostate is incomplete, we
investigated the keratin-phenotype of epithelial cells
in the prostate during various stages of human devel-
opment to see whether cells with an intermediate cell
keratin-phenotype could be identified. This may pro-
vide more information regarding the similarities be-




Tissue specimens used in this study comprised 11
prepuberal prostates taken during autopsy in 5 fetuses
(17, 19, 27, 32, and 38 weeks of gestation), 3 infants (2,
3.5, and 7 months old), and 3 prepubertal males (1
year and 4 months, 1 year and 7 months, and 11 years
old). For comparative purposes, prostate tissue from 5
adults (27–49 years old) was also used. Tissue blocks
were fixed in 10% phosphate-buffered formalin and
processed through paraffin. All patients died of non-
prostatically related diseases, and none of them had
been hormonally treated. Postmortem delay did not
exceed 10 hr (5.6 ± 2.4 hr). From each tissue block at
least five consecutive sections were cut. The tissue
block in the fetal prostate was a transversal section
through the entire prostate. In the adults, a represen-
tative section was taken without identifying the ana-
tomic location.
Antibodies
Four monoclonal antibodies were used in this study
and are summarized in Table I.
Briefly, RCK102 directed against K5 and K8 is a
broadly crossreacting keratin antibody. RCK102 stains
most epithelial tissues, while nonepithelial tissues do
not react with this antibody. We used RCK102 as a
general epithelial marker [20].
Monoclonal antibody 34bE12 recognizes K1, K5,
K10, and K14. As K1 and K10 are characteristic of
TABLE I. Characteristics of Monoclonal Antibodies Used in this Study
Antibody Specificity
Localization in
prostatic tissue Dilution Source Reference
RCK102 K5 and K8 All epithelial cells 1:10 Dr. G. van Muijen,
Nijmegen, Netherlands
20
34bE12 K1, K5, K10,
and K14
Basal cells 1:50 DAKO, Carpinteria, CA 21
RCK103 K5, etc. Basal and some
luminal cells
1:5 Dr. G. van Muijen,
Nijmegen, Netherlands
17,18
CK18 (clone DC-10) K18 Luminal cells 1:40 DAKO, Glostrup,
Denmark
16,22
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stratified keratinizing squamous epithelium, which is
not found in the prostate, this antibody recognizes K5
and K14 in prostatic tissue [21].
RCK103 recognizes K5 and a number of other ker-
atins that are not yet characterized. In the prostate it
reacts with basal cells and intermediate cells, and to
identify these last cells they must coexpress K18
[16,17].
CK18 (clone DC-10) recognizes K18. In the prostate
this keratin is found in luminal cells, for which it is
considered a marker [22].
Immunohistochemistry
Four-micrometer tissue sections were cut from par-
affin blocks, mounted on coated slides, and dried
overnight. After deparaffination, antigen retrieval was
performed: for CK18 (DC-10), microwave heating was
performed according to the manufacturer’s instruc-
tions. For the antibodies RCK102 and RCK103, antigen
retrieval was achieved according to a modified proto-
col [23] by submerging the slides in a 0.5% periodic
acid solution and microwave heating for two cycles of
5 min each (180 W). For 34bE12, slides were incubated
with 0.1% Pronase XIV solution (P-5147, Sigma
Chemical Co.,) dissolved in 10 mM Tris, 1 mM EDTA,
pH 7.5, at 37°C for 10 min. Sections were incubated
with the primary antibodies at 4°C overnight. Bioti-
nylated secondary antibody and AB complex were
used (Elite Vector ABC kit, Amersham, Burlingame,
CA). Peroxidase activity was visualized with diami-
nobenzidine (DAB) as a chromogen. Sections were
briefly counterstained in hematoxylin and cover-
slipped.
Evaluation of Keratin Immunostaining Results
The number of positively staining cells in the entire
section was estimated for the four keratin-antibodies
semiquantitatively and independently by two of us
(Y.X., F.S.). Any discrepancies were discussed and
consensus was reached in all cases. The number of
positive staining cells was estimated and recorded as
follows: −, no cells stained; +/−, incidental positive
cells, <1%; +, between 1–25% of cells; ++, between
26–50% of cells; +++, between 51–75% of cells; and
++++, between 76–100% of cells. Staining intensity
TABLE II. Comparison of Intermediate Cell Types Identified by Keratin Phenotyping in the Prostate
Characteristics of cell types Morphology
Developmental Present data
K14+/K5+/K18− Basally located in budding acini
K14±/K5±/K18± Intermediately located in budding acini
K14±/K5±/K18+ Luminally located in budding acini
K14−/K5−/K18+ Luminally located in budding acini
Normal adult References 15, 17, 18
K14+/K5+/K18− Spindle-shaped basal cells
K14+/K5+/PSA+ Spindle-shaped basal cells
K14−/K5+/K18+ Tall columnar luminal cells
K14−/K5−/K18+ Tall columnar luminal cells
Regenerating, BPH, and PCa References 16–18
K14+/K5+/K18− Spindle-shaped basal cells
K14−/K5+/K18− Basal-cell hyperplasia
K14+/K5+/PSA+ Spingle-shaped basal cells
K14−/K5+/K18+ Luminally-located, and some tumor cells
K14−/K5−/K18+ Tall columnar luminal cells, and tumor cells
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was not separately graded, as it was often heteroge-
neous within a specimen and between specimens. The
pattern of staining, however, was constant. Staining
was evaluated separately for the three cell types in the
budding tips, also referred to as the distal compart-
ment (see Results), and for the more proximal tubules
referred to as the ductal compartments which are di-
rectly adjacent to the urethral orifice and which show
immature glandular lumens. Positive controls con-
sisted of prostate tissues from surgery specimens,
which are known to react strongly with the antisera
used [17]. Bovine serum albumin was used instead of
the primary antibodies for negative controls.
RESULTS
Light Microscopy
Topographically, prostate epithelial cells could be
subdivided into three types, and are illustrated sche-
matically in Table II. First, basally located cells were
directly adjacent to the basal membrane, which sepa-
rated them from the stromal compartment. These cells
had no direct contact with glandular lumen. Second,
intermediately located cells were found above the
basal cells and underneath the luminally located cells
which lined the prostate acinus. In early development,
many layers of these suprabasal cells were seen in
solid cords in the peripheral zone of prenatal and in-
fantile prostate. Third, luminally located cells lined the
acini. Under them, basally located cells and sometimes
intermediately located cells were found. In early de-
velopment, it was not easy to identify these cells sepa-
rately.
The epithelial compartment of the 17- and 19-week
fetuses consisted of budding solid cords of cells in the
peripheral parts of the gland, surrounded by highly
cellular stroma (Fig. 1a). The basement membrane was
inconspicuous. Cells in the solid cords had relatively
large ovoid nuclei and scant cytoplasm. Columnar
cells were not recognizable. Luminal differentiation
was found in the proximal parts of the tubules. The
luminal portion of these ducts was lined by noncili-
ated low columnar or cuboid cells with underlying
multilayered basaloid cells. In the 27-week fetus and
in the older fetuses, the branching process started to
appear in the peripheral parts of the prostate. It was
characterized by increased numbers of solid buds and
tubules lined by epithelium, similar to those found in
the younger fetus. The ducts in the vicinity of the ure-
thra were sometimes lined by squamous metaplastic
epithelium (Fig. 2c).
The prostates from the 4 infants showed a histo-
logic picture different from that of the fetuses. The
number of developing solid cords had increased and
also the number of ducts. The stroma was a little less
cellular. The basally located cells were the same as in
the fetus, but more cords had lumina lined by colum-
nar cells.
In the two prostates from children, 16 and 19
months old, solid cords of epithelial cells were mostly
replaced by arborizing tubules lined by one or more
Fig. 1. H&E-stained tissue sections from prostate. a: 11-week
fetus. b: 11-year-old male. c: 49-year-old male. Original magnifica-
tion: objective ×40.
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Fig. 2. Immunoperoxidase staining pattern of developing (a,c,e,g) and adult (b,d,f,h) prostate after staining with RCK102 (a,b), 34bE12
(c,d), RCK103 (e,f), and CK18 (g,h). Tissue sections were from prostates of (a) 19-week fetus, (c) 32-week fetus, (e) 11-year-old male,
and (g) 32-week fetus. Arrow indicates squamous metaplastic epithelium (c). Original magnification: objective ×40.
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TABLE III. Cellular Keratin Phenotype on Budding Tips of Developing Acini and Mature Glands in the Prostate*
Age Site RCK102 34bE12 RCK103 CK18
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layers of small cells with relatively large nuclei and
scant cytoplasm. Luminal low columnar or cuboidal
cells, usually with large central nuclei, were also seen.
Polarity and secretory vacuoles in the supranuclear
portion were hardly discernible, and often it was dif-
ficult to distinguish these cells from adjacent cells with
more basaloid features. The prostate of the prepuber-
tal 11-year-old male basically showed the same picture
as in the infants, especially in the distal segment of the
ductal acini. This was characterized by a more elabo-
rate formation of arborizing irregularly-shaped glands
consisting of a single layer of small spindle-shaped
basal cells underlying a single layer of tall columnar
luminal cells with periapical vacuolation of their cy-
toplasm. Stroma was still predominant but less cellu-
lar in comparison to younger prostates (Fig. 1b). For
comparison, the histology of adult prostate acini is
shown in Figure 1c.
Keratin Immunophenotyping
Keratin expression was separately evaluated in the
distal segment of branching glandular structures or
budding tips, and in the proximal ductal compartment
associated with the urethra, for the basally-located,
intermediately-located, and luminally-located cells.
Keratin Immunophenotyping in the Developing
Prostate (Table III, Fig. 2)
Basally-located cells. In 9 of 11 developing prostates,
all basally-located cells were positive for RCK102 and
34bE12 (Fig. 2a,c). In 2 cases about half of the basally-
located cells stained for 34bE12. Monoclonal antibody
RCK103 was intensely immunoreactive with basally
located cells in both budding tips and ducts of the
developing prostate (Fig. 2e). However, there was
some variability in the number of positively staining
cells, and in 3 cases approximately 50% of cells
stained, and one case was negative. CK18 was not
expressed in the basal-cell compartment of any of the
cases (Fig. 2g).
Intermediately-located cells. In all but 2 cases, all in-
termediately located cells stained with the RCK102 an-
tibody (Fig. 2a). 34bE12, a marker for basal cells,
stained 50–75% of cells in the intermediate compart-
ment of 10 cases (Fig. 2c), while in one case only spo-
radic cells stained. RCK103 stained the cells in this
compartment in most cases. However, the percentage
of cells staining was considerably lower than that
found in the basal compartment (Fig. 2e). In one case,
only sporadic cells stained. CK18 was detected in 10
cases in the intermediate compartment. One case was
negative. Immunoreactivity was variable, with 4 cases
showing positivity in 50% of cells, 2 cases showing
positivity in 25% of cells, and 4 cases showing only
sporadic staining (Fig. 2g).
Luminally-located cells. RCK102 was positive in all
cases in most cells (Fig. 2a). In 9 cases, between 25–
50% of luminal cells stained with 34bE12 (Fig. 2c). In
TABLE III. Continued












*A completely solid bar indicates that between 75–100% of cells stained. A 3⁄4 solid bar indicates that between 50–75% of cells stained.
A 1⁄2 solid bar indicates that between 25–50% of cells stained. A 1⁄4 solid bar indicates that between 1–25% of cells stained. An open bar
indicates that no cells stained. Horizontal lines mean incidental positive in <1% of cells. B, basally located cells; I, intermediately
located cells; L, luminally located cells; NA, not available; F, fetus. For details of scoring, see Materials and Methods.
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one case, only sporadic cells were immunoreactive,
and in one case the luminal compartment was nega-
tive. The cases with the least reactivity were the infant
and the prepubertal prostate. In most cases, RCK103
showed the same or slightly less immunoreactivity
than with intermediately-located cells (Fig. 2e). In one
case, only sporadic cells stained, and one other case
was completely negative. Keratin 18 was detectable in
the luminally-located cells of all cases. However, the
percentage of positive cells varied. In 6 cases, virtually
all cells in the luminal compartment stained (Fig. 2g),
in 3 cases, 75%, in one case, 50%, and in one other case,
only 25%. For K18, there seemed to be a trend toward




In general, ductal compartments showed immuno-
reactivity that paralleled that of the budding tips.
Only salient features of keratin phenotyping are de-
scribed. Differential expression of the various keratin
antibodies between basal and luminal cells was often
more obvious. Most striking was the focal expression
of RCK103 in the luminal cell compartment, with
34bE12 showing positivity in 2 cases. In the fetuses of
17 and 27 weeks of gestation, ductal structures were
not observed in the slides.
Keratin Immunophenotyping in Adult Prostate
Keratin expression in the adult prostate was the
same as previously described in frozen sections [17].
Basal cells intensely expressed 34bE12 and RCK103,
while CK18 was not expressed (Fig. 2d,f,h). Luminal
cells only expressed CK18. However, 3 cases showed
sporadic RCK103 positivity, and one case showed
scanty expression of 34bE12. RCK102 was positive in
almost all epithelial cells in the adult prostate (Fig. 2b).
DISCUSSION
Luminal and basal cell types encountered in the
adult prostatic epithelium are two distinctly different
cellular populations with regard to structure and func-
tion [24,25]. Early reports suggested that they origi-
nate independently [6,26,27]. More recent studies,
however, provide evidence for the existence of a plu-
ripotent progenitor cell type for luminal cells [28]. Ul-
trastructural studies on human, rat, and dog prostatic
tissue suggest that basal cells are actively engaged in
growth. They are not highly specialized in a structural
sense but resemble undifferentiated secretory epithe-
lial cells [12,13,24]. In the developing prostate, how-
ever, the typical morphologic basal-cell and luminal-
cell features could not be readily identified.
Early studies on prostate development were based
mainly on light and electron microscopic results. They
showed that the prostatic buds appear at about week
12 of amenorrhea. The buds are formed from the mu-
cosa of the urogenital sinus, which protrudes through
the basement membrane to colonize the surrounding
mesenchyme. Initially they are solid budding tips
composed of monotonous cells with basaloid appear-
ance. Ultrastructural studies show that at 13 weeks of
gestation, luminal cells with dense secretion granules
and nuclear polarization may be identified in the aci-
nar lumen. The other cells present in these acini are
less well-differentiated and have been hypothesized to
represent the equivalents of basal cells in the adult
prostate [29–31].
Antibodies to cytoskeletal proteins of the keratin
subclasses have been used as a relatively new tool to
study embryonic development, particularly with re-
gard to differentiation [7,26, and references therein].
These studies show that changes in levels of differen-
tiation are accompanied by distinct transitions in ex-
pression of individual keratins. In the present report
we investigated whether application of a small panel
of keratin antibodies could give a more profound in-
sight into prostatic differentiation. And as such, this is
an extensive report describing keratin expression in
the fetal prostate. Due to the absence of keratin anti-
bodies specific for intermediate cells, they are identi-
fied by their coexpression of antibodies RCK103 and
CK18, and actually this MAb RCK103 is mainly found
in the basal cell compartment. In a previous study we
found that epithelial cells in the adult prostate could
be characterized into basal cells (K14+/K5+/K18−), lu-
minal cells (K14−/K5−/K18+), and intermediate cells
(K14−/K5+/K18+). We have suggested that these cells
could well be the missing link between basal and lu-
minal cell types during differentiation, and that they
could play a role in neoplastic transformation in the
adult prostate [17]. An interesting question is whether
this cell type is present in the developing prostate, and
if so when may it first be identified?
At 17 weeks of gestation, we observed variable dif-
ferentiation-specific keratins in the immature prostate.
Basally-located cells were positive for both 34bE12
and RCK103, but negative for CK18. Therefore, their
keratin phenotype was K14+/K5+/K18−. This pattern
is the same as that of spindle-shaped basal cells in
adult prostates [17,18]. Most probably these basally-
located cells are the same as adult prostate basal cells,
which have proliferative potential [12,32].
The luminally-located cells were partially positive
for 34bE12 and RCK103, and practically all contained
K18. Therefore, their kerat in phenotype is
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K14±/K5±/K18+. These cells have a keratin phenotype
different from that of their adult counterparts (K14−/
K5−/K18+). This could be explained by contending
that even though they are luminally located they are
still not fully differentiated luminal cells, and that they
still have basal-cell and intermediate-cell characteris-
tics in terms of their keratin phenotype despite their
luminal location, meaning that the morphologic tran-
sition of these cells, from basaloid to luminal, is pre-
ceded by a transition in keratin-phenotype. In some
adult prostatic tissues we also noticed that sporadic
cells in the luminal compartment had the basal-cell
keratin-phenotype. This is consistent with previous re-
ports and is probably associated with focal basal-cell
hyperplasia [18,33]. Furthermore, comparing the inter-
mediate cell type between the human adult prostate
and the developing prostate, previous studies never
found that intermediate cells express basal-cell keratin
34bE12 in the adult.
The intermediately-located cells displayed a hetero-
geneous keratin phenotype coexpressing both keratins
found in basal and luminal cells (K14±/K5±/K18±).
Furthermore, there are cells expressing basal keratins
only and a number of cells expressing luminal-cell
keratins only. It is possible that this intermingled pat-
tern indicates the underlying gradual switch from
basal cells with K14 and K5 phenotype to luminal cells
with K18. This would strongly favor the role of these
cells as intermediate cells that stemmed from basal
cells and that will eventually differentiate into luminal
cells. The simultaneous expression of both Kbasal (K5 +
14) and Kluminal (K18) is substantial evidence that these
intermediately located cells are truly in an intermedi-
ate state of differentiation. In Table II, we summarize
the keratin differential expression patterns in compari-
son with previous results. The identification of the
intermediate cell type in the fetal prostate reveals that
the hierarchical expanding pathway from basal to lu-
minal cells may be demonstrated in the most early
stages of development. The fact that these cells are
present in the fetus may indicate that they have a
regulatory function in prostate development. Since the
same intermediate cell type can be identified in the
adult, this potential to transform probably remains
throughout life. Pathologic stimulation, e.g., aging
hormonal alteration, or disturbance in homeostasis
(stromal-epithelial interactions), may reactivate this
process, inducing profound changes resulting in ab-
normal accumulation of specific cell types. For in-
stance, castration induces basal-cell hyperplasia, while
luminal cells are either lost entirely or decrease in
number [16], indicative of an androgen-independent
proliferative function [25,34]. The abnormal accumula-
tion of these specific cell types in the adult may be con-
tributory in the development of BPH or even PCa [35].
We conclude that in the fetal prostate, morphologic
cell differentiation is preceded by differential keratin
expression. In early stages of prostate development,
cells with an intermediate keratin phenotype may be
identified. The large numbers of these cells may reflect
their position as a link between basal and luminal cells
in a differentiation pathway.
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